Odabas H - Search Results

1

Safety and efficacy of FOLFIRI-bevacizumab for metastatic colorectal carcinoma as second line treatment.

Odabas H, Ozdemir N, Isik M, Abali H, Oksuzoglu B, Kos T, Civelek B, Babacan AN, Dogan U, Zengin N. Odabas H, et al. J BUON. 2011 Jul-Sep;16(3):460-3. J BUON. 2011. PMID: 22006750

2

Exploring the Clinical Impact of RANK Pathway Inhibition in Advanced Breast Cancer: Insights From a Retrospective Study on CDK4/6 Inhibitors and Antiresorptive Therapy.

Akdag G, Dogan A, Yildirim S, Kinikoglu O, Mokresh ME, Alomari O, Turkoglu E, Isik D, Sürmeli H, Basoglu T, Sever ON, Odabas H, Yildirim ME, Turan N. Akdag G, et al. Among authors: odabas h. Cureus. 2024 Jun 28;16(6):e63362. doi: 10.7759/cureus.63362. eCollection 2024 Jun. Cureus. 2024. PMID: 39070363 Free PMC article.

3

Gemcitabine and cisplatin in patients with carcinoma of unknown primary site.

Isik M, Seker MM, Odabas H, Kos FT, Uncu D, Zengin N. Isik M, et al. Among authors: odabas h. Med Oncol. 2011 Jun;28(2):591-6. doi: 10.1007/s12032-010-9465-8. Epub 2010 Mar 19. Med Oncol. 2011. PMID: 20300978

4

Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer.

Kos FT, Uncu D, Ozdemir N, Budakoglu B, Odabaş H, Abali H, Oksuzoglu B, Aksoy S, Zengin N. Kos FT, et al. Among authors: odabas h. Chemotherapy. 2011;57(3):230-5. doi: 10.1159/000327840. Epub 2011 May 18. Chemotherapy. 2011. PMID: 21597287

5

First-line therapy for metastatic colorectal carcinoma: modified FOLFOX4 or FOLFIRI-bevacizumab.

Odabas H, Ozdemir N, Abali H, Oksuzoglu B, Isik M, Uncu D, Cihan S, Seker M, Zengin N. Odabas H, et al. J BUON. 2011 Apr-Jun;16(2):247-52. J BUON. 2011. PMID: 21766493

6

Gastric adenocarcinoma under the age of 40; more metastatic, less differentiated.

Isik M, Caner S, Metin Seker M, Civelek B, Odabas H, Ozdemir N, Uncu D, Zengin N. Isik M, et al. Among authors: odabas h. J BUON. 2011 Apr-Jun;16(2):253-6. J BUON. 2011. PMID: 21766494

7

Long term survival in a metastatic alveolar soft part sarcoma at the time of diagnosis: a case with 17 years of follow-up.

Kos FT, Uncu D, Oksuzoglu B, Aksoy S, Ozdemir N, Odabas H, Isik M, Civelek B, Zengin N. Kos FT, et al. Among authors: odabas h. J BUON. 2011 Apr-Jun;16(2):376-7. J BUON. 2011. PMID: 21766518 No abstract available.

8

Adjuvant modified FOLFOX-4 in patients with stage III rectum adenocarcinoma.

Cihan Ş, Uncu D, Babacan NA, Özdemir N, Odabaş H, Aksoy S, Öksüzoğlu B, Zengin N. Cihan Ş, et al. Among authors: odabas h. Asian Pac J Cancer Prev. 2011;12(4):967-70. Asian Pac J Cancer Prev. 2011. PMID: 21790235 Free article.

9

Adjuvant therapy for gallbladder and bile duct cancers: retrospective comparative study.

Tugba Kos F, Aksoy S, Odabas H, Ozdemir N, Oksuzoglu B, Uncu D, Zengin N. Tugba Kos F, et al. Among authors: odabas h. J BUON. 2011 Jul-Sep;16(3):464-8. J BUON. 2011. PMID: 22006751

10

Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective study.

Bulent Akinci M, Algin E, Inal A, Odabas H, Berk V, Coskun U, Uyeturk U, Isikdogan A, Aksoy S, Civelek B, Sevinc A, Buyukberber S. Bulent Akinci M, et al. Among authors: odabas h. J BUON. 2013 Apr-Jun;18(2):314-20. J BUON. 2013. PMID: 23818340 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters